Atherosclerosis is a complex and progressive cardiovascular condition that involves the gradual buildup of plaque in the arteries, restricting blood flow and potentially leading to serious health complications. This condition stems from the accumulation of cholesterol, fats, and inflammatory cells on the inner walls of arteries, forming atherosclerotic plaques. As these plaques grow, they can narrow the arteries, impeding the smooth flow of blood to vital organs and tissues. Atherosclerosis is a significant contributor to various cardiovascular diseases, including heart attacks, strokes, and peripheral artery disease. Risk factors for developing atherosclerosis include high cholesterol levels, hypertension, smoking, diabetes, and a sedentary lifestyle. Understanding the underlying mechanisms of atherosclerosis is crucial for developing effective prevention and treatment strategies. Lifestyle modifications, such as adopting a heart-healthy diet, regular exercise, and managing risk factors, play a pivotal role in mitigating the progression of atherosclerosis and promoting overall cardiovascular health. Ongoing research continues to unravel the intricacies of atherosclerosis, paving the way for innovative therapies and interventions aimed at reducing its impact on global health
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation